Clinical Trial Update: Belatacept Conversion in Proteinuric Kidney Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on converting to belatacept in proteinuric kidney transplant recipients; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection
• Proteinuria

Drugs mentioned

• belatacept (belatacept)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Proteinuria | Phase 2 | Status: COMPLETED | Results posted: 2022-11-09